Immune cells with a senescence-associated secretory phenotype increase in the blood of elderly individuals or individuals with age-associated diseases or with infections. Although senescent immune cells do not proliferate, they are transcriptionally and metabolically active and affect the microenvironment through the secretion of proinflammatory mediators. An age-driven increase in senescent B, T and NK cells has been reported and the function of these cells has been characterized. Results published by different groups have demonstrated that cell senescence induces the accumulation of terminally-differentiated cells characterized by the arrest of cell proliferation but with an active secretory profile which regulates their function through the activation of pathways integrating senescence and energy-sensing signals. This review will focus on senescent B cells, their increase in aging, age-associated conditions and infections. Similarities with other senescent immune cells will be presented and discussed.
Introduction
Aging is characterized by increased low-grade chronic inflammation, called "inflammaging" (Franceschi et al., 2000) , which represents a significant risk factor for morbidity and mortality of elderly individuals as it is implicated in the pathogenesis of several disabling diseases of the elderly, including Type-2 Diabetes, osteoporosis, Alzheimer's disease, Rheumatoid Arthritis, atherosclerosis and coronary heart disease (Alexopoulos et al., 2014; Holmes et al., 2009; Isaacs, 2009; Libby, 2012; Lindholm et al., 2008; Mundy, 2007; Sarzi-Puttini et al., 2005) . Circulating inflammatory mediators such as cytokines and acute phase proteins, are markers of inflammaging. Among these, elevated serum levels of IL-6 and C-Reactive Protein, have been shown to predict 3-year mortality in the elderly by the Invecchiare in Chianti study (Alley et al., 2007) .
The ways in which inflammaging contributes to adverse health outcomes is not completely understood, and therefore the identification of pathways controlling inflammaging across multiple systems is important, in order to design protocols of intervention to reduce inflammaging and potentially improve the health of elderly individuals.
Several factors contribute to inflammaging, including polymorphisms in the promoter regions of pro-inflammatory genes, chronic stimulation of immune cells with viruses such as cytomegalovirus (CMV), obesity, changes in the gut microbiome, increased permeability from the intestine [reviewed in ]. Cellular senescence has also been proposed to be a significant contributor to inflammaging, due to the acquisition of the senescence-associated secretory phenotype (SASP) by fibroblasts (Freund et al., 2010 ), endothelial Experimental Gerontology 107 (2018 
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Experimental Gerontology j o u r n a l h o m e p a g e : w w w . e l s e v i e r . c o m / l o c a t e / e x p g e r o cells and immune cells (Sikora et al., 2011) . A largescale characterization of the SASP has been performed in fibroblasts and endothelial cells using antibody arrays to quantitatively measure pro-inflammatory mediators, such as cytokines, chemokines, micro-RNAs, growth factors and proteases (Campisi, 2011) . Work under way is aiming at thoroughly characterize the senescent secretome of immune cells.
Senescent cells are characterized by the arrest of cell proliferation and have short telomeres, but they are transcriptionally and metabolically active. This high activity of senescent cells derives from the SASP, which leads to the secretion of multiple factors with potent biological activities on surrounding cells and tissues.
The term "senescence" has recently generated controversy within the aging field, especially because the arrest of cell proliferation has been observed in highly differentiated immune cells which can secrete multiple factors regulating their function. In the case of B cells, these highly differentiated cells represent the terminally-differentiated subset, as they derive from IgM or switched memory B cells (Bagnara et al., 2015) . This process of differentiation seems to occur through the activation of non canonical pathways integrating senescence (Frasca et al., 2017a) and energy-sensing signals (Torigoe et al., 2017) , similar to what has been shown for T Henson et al., 2015; and NK (Muller-Durovic et al., 2016) cells.
Changes in glucose levels in the extracellular milieu occur with age (Spazzafumo et al., 2013) , and may be responsible for decreased function, as B cells utilize glucose for proliferation and differentiation (Caro-Maldonado et al., 2014) , as it has also been shown for T cells (Heikamp and Powell, 2012; Verbist et al., 2012; Xu et al., 2012) and macrophages (Recalcati et al., 2012) . Briefly, T cell activation leads to metabolic reprogramming characterized by a rapid increase in the expression of glucose transporters to support glycolysis over oxidative metabolism and pathways of this metabolic reprogramming have been characterized (Frauwirth et al., 2002; Rathmell, 2012) . Similar to T cells, B cells also increase the expression of glucose transporters and mitochondrial mass upon mitogen or antigen stimulation, and deletion of glucose transporters reduces B cell numbers and antibody production (Caro-Maldonado et al., 2014) . Experiments in our laboratory are currently evaluating the energy metabolism of the different B cell subsets, by performing gene expression analysis of pathways related to the glucose metabolism, measuring glucose uptake upon cell stimulation, and determining mitochondrial morphology, abundance and function.
Senescent B cell subsets are increased in the blood of healthy elderly individuals
Inflammaging is associated with changes in the distribution of B cell subsets in the peripheral blood. Four major peripheral B cell subsets can be measured by flow cytometry in the human blood: naive (IgD +/ CD27 −), IgM memory (IgD +/CD27 +), switched memory (IgD −/ CD27 +), late memory (LM, IgD−/CD27−). We have shown that LM B cells are increased in percentages (and numbers) in the blood of healthy elderly versus young individuals (Frasca et al., 2017a; Frasca et al., 2017b; , similar to what has also been reported by other groups Rinaldi et al., 2017) . Phenotypic and functional characteristics of LM B cells are summarized in Table 1 .
The frequency of LM B cells in blood has been found to be negatively associated with a protective response against the influenza vaccine, measured by hemagglutination inhibition assay at t28 (1 month after influenza vaccination) (Frasca et al., 2017a) , or by the frequency of plasmablasts in blood at t7 (1 week after influenza vaccination) (Rinaldi et al., 2017) . Both measures represent good correlates of vaccine protection. This negative association was expected, based on the fact that this B cell subset is highly inflammatory and has been reported to show characteristics of cell senescence, such as poor ability to proliferate in vitro in response to mitogenic stimulation and reduced telomerase activity (Colonna-Romano et al., 2009; Martorana et al., 2014).
Although LM B cells do not proliferate in vitro in response to mitogenic stimulation, they are transcriptionally active. In our recently published work (Frasca et al., 2017a) , we have evaluated the functional quality of the B cell pool, as this influences the individual's response. We have shown that unstimulated memory but not naïve B cells from both young and elderly individuals, evaluated at t0 (before vaccination), express RNA for multiple SASP markers, such as the pro-inflammatory cytokines TNF-α/IL-6/IL-8 and for the pro-inflammatory micro-RNAs (miRs)-155/16/93. Levels are higher in B cells from elderly versus young individuals. Among memory B cell subsets, the LM subset expresses the highest level of SASP markers.
Unstimulated memory but not naïve B cells from both young and elderly individuals also express RNA for p16 INK4 with the LM subset showing the highest levels of this SASP marker. The fact that switched memory and IgM memory B cells from elderly individuals show higher levels of expression of SASP markers as compared to younger individuals may help to explain their decreased function in the elderly. Through secretion of these pro-inflammatory mediators, LM B cells affect the microenvironment and in turn sustain and propagate the inflammatory response and negatively regulate the function of other immune cells. We have indeed previously shown that the levels of endogenous TNF-α in B cells negatively impact their ability to proliferate, differentiate and generate optimal antibody responses (Frasca et al., 2014 ). These results demonstrate that basal (pre-stimulation) levels of TNF-α in B cells negatively impact the ability of the same B cells to generate optimal function. Moreover, pre-incubation of B cells with an anti-TNF-α antibody, before in vitro stimulation, significantly increase B cell function, indicating that it is possible to improve B cell function and antibody production by counteracting intrinsic levels of TNF-α (Frasca et al., 2014) . Recent evidence from our laboratory has shown that if LM cells are sorted out from the total B cell pool, class switch increases, and more in individuals with high endogenous levels of TNF-α (manuscript in preparation). LM B cells are also characterized by CD95 high , CD21 low , T-bet and CD11c expression as compared to the other B cell subsets (Frasca et al., 2017b and down-regulation of CD21 (complement receptor type 2, complement C3d receptor, or Epstein-Barr virus receptor) (Moir et al., 2008) have been shown to be independently associated with B cell activation. Moreover, experiments in mice have shown that T-bet + CD11c + B cells are potent antigen-presenting cells in viral immunity and autoimmunity (Rubtsov et al., 2015) . It is likely that the in vivo accumulation of LM B cells with age is due to the terminal differentiation of subsets that have undergone class switch after (chronic) exposure to antigens such as CMV and we have evidence (unpublished) that LM B cells increase 3-4 fold in the blood of CMV-seropositive individuals as compared to CMV-seronegative controls. We believe that these cells control latent infections through the secretion of specific IgG antibodies. Similarly, these cells may accumulate in response to autoantigen stimulation, and they may secrete IgG antibodies, such as anti-nuclear and anticardiolipin, which are frequently found in the blood of healthy elderly individuals. Both hypotheses still need to be validated.
LM B cells express markers associated with homing to sites of inflammation, including the chemokine receptor CXCR3 and CD11c (Frasca et al., 2017b) , the expression being higher in LM from the elderly than in those from the young, suggesting that these cells may migrate to inflamed tissues and contribute to local inflammation by secretion of pro-inflammatory mediators. The ligands of CXCR3, CXCL9 and IP10 (CXCL10), are indeed expressed by endothelial and epithelial cells in inflamed tissues and B cells expressing CXCR3 can directly enter these tissues from the blood.
The expression of SASP markers in LM B cells (but not in IgM memory B cells) is associated with activation of NF-kB, due to spontaneous activation of AMP-activated protein kinase (AMPK), the energy-sensing enzyme and key metabolic regulator ubiquitously expressed in mammalian cells (Ruderman and Prentki, 2004) . This leads to spontaneous p38MAPK and NF-kB activation, suggesting that senescence and energy-sensing signaling pathways converge to regulate functional responses in these cells (Frasca et al., 2017a) .
Similar to LM B cells, terminally-differentiated CD4 + T cells Henson et al., 2015; Lanna et al., 2014) show spontaneous activation of AMPK which leads to the recruitment of p38MAPK to the scaffold protein TAB1 and consequent p38MAPK phosphorylation, resulting in inhibition of telomerase activity, T cell proliferation and TCR signaling.
NK cells showing high expression of the inhibitory killer cell lectinlike receptor (KLRG1) increase with aging, are considered terminallydifferentiated and are less functional as compared to those that are KLRG1 low . This has been associated with spontaneous phosphorylation of AMPK which is further amplified by ligation of KLRG1 on the surface of these cells, leading to impaired cytotoxicity, IFN-γ production, telomerase activity and proliferation (Muller-Durovic et al., 2016) .
We believe that the signaling pathways leading to the spontaneous activation of AMPK in terminally-differentiated B, T and NK cell subsets should be interrogated as the detrimental effects of chronic AMPK activation may overshadow the beneficial systemic effects of treatments like Metformin, now used in clinical trials to target aging and age-related diseases (i.e. "Targeting Aging with Metformin", TAME clinical trial).
Senescent B cell subsets in age-associated diseases and infections
The senescent LM B cell subset is significantly increased in the blood of patients with Rheumatoid Arthritis (Adlowitz et al., 2015) , SLE (Wehr et al., 2004) , Multiple Sclerosis (Claes et al., 2016) , Sjogren (Saadoun et al., 2013) or Alzheimer's disease Martorana et al., 2014) ; in the blood of individuals infected with HIV (Meffre et al., 2016; Moir et al., 2008) , Hepatitis C (Chang et al., 2016) or malaria (Illingworth et al., 2013; Portugal et al., 2015) ; in the blood of individuals with obesity . In all the conditions above, senescent LM B cells have been called with different names, such as tissuelike, double negative, or atypical memory B cells. Nevertheless, they represent the most pro-inflammatory B cell subset, with low proliferative capacity and an immune activated phenotype characterized by the expression of CD95 high , CD21 low , CD11c, T-bet. These cells also express inhibitory receptors (FcR-like family), leading to decreased B cell receptor signaling, impaired proliferation and antibody production.
The fact that LM B cells are increased in the blood of patients with autoimmune and infectious diseases suggests that these cells may expand in vivo in the presence of autoantigens or pathogen-derived antigens, in the context of a favorable inflammatory microenvironment, leading to the production of pathogenic (autoimmune) or virus-specific antibodies, respectively. In HIV-infected individuals it has indeed been reported an enrichment of HIV-specific (HIV envelope gp120) antibody responses within the subset of LM B cells (called tissuelike in HIV-infected individuals), whereas influenza-specific antibody responses have only been observed in classical memory B cells (Moir et al., 2008) .
Conclusions
Lymphocyte metabolism has been shown to regulate the function of immune cells. Specific signaling pathways provide energy to support cell function. However, if energy sources or metabolic pathways of lymphocytes are dysregulated, as it has been shown to occur during aging, metabolic checkpoints can become activated and cell function becomes impaired.
Results reported in this review clearly indicate that during aging not only senescence-associated signaling but also "non canonical" energysensing signaling pathways become activated and these may be responsible for the accumulation of dysfunctional terminally-differentiated immune cells. The observation that in elderly individuals B, T and NK cells (and maybe also other immune cells) share these signaling pathways suggests the possibility to use a single therapeutic intervention (for example diet) to target different cell types and improve the health of the elderly population.
